Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
39.75
-0.64 (-1.58%)
Jul 21, 2025, 4:00 PM - Market closed
AAPG Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for AAPG.
Price Target: n/a
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for AAPG is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 27, 2025 |
Financial Forecast
Revenue This Year
529.96M
from 980.65M
Decreased by -45.96%
Revenue Next Year
2.59B
from 529.96M
Increased by 389.09%
EPS This Year
-3.10
from -1.34
EPS Next Year
2.33
from -3.10
Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 625.8M | 3.4B | 2.9B | ||
| Avg | 530.0M | 2.6B | 1.7B | ||
| Low | 402.8M | 1.5B | 758.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -36.2% | 537.0% | 13.5% | ||
| Avg | -46.0% | 389.1% | -35.8% | ||
| Low | -58.9% | 179.1% | -70.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.27 | 4.34 | 3.15 |
| Avg | -3.10 | 2.33 | -0.05 |
| Low | -3.92 | -0.90 | -1.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 35.1% |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.